Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionCalcium channel, voltage‐gated (Cav3.2, T‐type) blocker
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat diabetic neuropathic pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today